Biological Matrices Versus Synthetic Meshes

Last updated: February 3, 2025
Sponsor: University Hospitals of Derby and Burton NHS Foundation Trust
Overall Status: Active - Recruiting

Phase

N/A

Condition

Breast Cancer

Cancer

Treatment

One-stage immediate breast reconstruction

Clinical Study ID

NCT05449691
315581
  • Ages > 18
  • Female

Study Summary

In this feasibility study, 60 women undergoing reconstruction will be randomly allocated to receive biological or synthetic mesh and followed for 6 months. The findings will tell us if patients and surgeons are comfortable with not being able to choose which mesh is used for the operation. In the larger surgical study, the investigators plan to measure patients' satisfaction with the reconstruction, patients' quality of life, complications from the operation and costs over 5 years.

Eligibility Criteria

Inclusion

Inclusion Criteria:

Female age ≥ 18 Women undergoing mastectomy and immediate one-stage mesh assisted implant breast reconstruction as standard treatment

Exclusion

Exclusion Criteria:

Revision reconstruction surgery Delayed reconstruction surgery

Study Design

Total Participants: 60
Treatment Group(s): 1
Primary Treatment: One-stage immediate breast reconstruction
Phase:
Study Start date:
November 02, 2023
Estimated Completion Date:
April 30, 2026

Study Description

Immediate breast reconstruction in women undergoing removal of the whole breast for cancer or risk reduction is most commonly done using breast implants. Surgeons often use a sheet of mesh to cover the implant as standard treatment. It acts like an internal bra and supports the implant and re-creates a natural looking breast.

Natural(biological) or man-made (synthetic) meshes are used routinely in the NHS. Biological ones are made from animal tissue (pig, cow) that have been made safe to use in people and are costly. Synthetic meshes are made from net-like fabric and cost less. The choice about which mesh to use depends on surgeons' personal experience and how much money the hospital has for these operations. The two meshes may have different acceptability issues for patients because of their personal values, religious beliefs, ethnic background or views on animal welfare.

A large UK review of breast reconstruction with implants gathered information up to 3 months after surgery on the use and outcomes of the two meshes. This suggests that both may be equally safe in the short-term. However, this information can be improved by comparing the meshes side-by-side and looking at how safe they are long-term. This is important as some side-effects only appear later after surgery. Clinicians do not know how outcomes impact on patients' health and well-being.

The best proof would come from a randomised surgical study, where a computer allocates patients to receive either the biological or synthetic mesh. Investigators will measure how patients feel, how their health is, and record if they have any side-effects from the reconstructive surgery. This type of study would tell us how good each mesh is and if they are safe long-term.

Before starting such a study, investigators will run a smaller one that will help us understand if patients and surgeons would be comfortable taking part.

Connect with a study center

  • University Hospitals of Derby and Burton NHS Foundation Trust

    Derby, DE22 3NE
    United Kingdom

    Active - Recruiting

  • Castle Hill Hospital

    Hull,
    United Kingdom

    Active - Recruiting

  • University Hospitals of Leicester NHS Trust

    Leicester,
    United Kingdom

    Active - Recruiting

  • Nottingham City Hospital

    Nottingham,
    United Kingdom

    Active - Recruiting

  • Wycombe Hospital

    Wycombe,
    United Kingdom

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.